Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | OT |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
patient was administered MMR II while currently being on an immunosuppressive medication HUMIRA for rheumatoid arthritis; No additional AE; This spontaneous report was received from a physician and refers to a 40-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions included rheumatoid arthritis. Concomitant medications included Humira (Adalimumab) . On an unknown date, the patient started therapy with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), administered by Intramuscular route (lot # and expiration date were not reported) for MMR Vaccination protection. The patient was administered MMR II while currently being on an immunosuppressive medication adalimumab (HUMIRA) for rheumatoid arthritis (contraindicated product administered). No additional AE (no adverse event).
Rheumatoid arthritis
HUMIRA